This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_FEMALE_GENITAL_NAS_EXALLC for full statistics.
Malignant neoplasm of other and unspecified female genital organs
C3_FEMALE_GENITAL_NAS
Genital neoplasm, female: Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
437 |
4. Check minimum number of eventsNone |
437 |
5. Include endpointsNone |
437 |
6. Filter based on genotype QC (FinnGen only) |
437 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified female genital organs
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 437 | 437 | - |
| Unadjusted period prevalence (%) | 0.15 | 0.15 | - |
| Median age at first event (years) | 68.44 | 68.44 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 401
- Matched controls
- 4009
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
128
Kela drug reimbursment
Cancers of female genital organs
235.6
313.2
296
47
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
1637.0
257.4
223
*
8461/3-C57.0
ICD-O-3
High grade serous carcinoma of fallopian tube
+∞
210.6
183
*
H02AB02
ATC
dexamethasone; systemic
27.0
172.8
280
316
JAL30
NOMESCO Finland
Omentectomy
87.4
158.4
172
34
A04AA01
ATC
ondansetron; systemic, rectal
26.7
152.4
231
194
A03FA01
ATC
metoclopramide; systemic, rectal
16.6
134.0
314
717
R18
ICD-10 Finland
Ascites
53.7
113.0
134
37
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
73.0
112.4
126
25
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
477.7
110.1
105
*
B01AB10
ATC
tinzaparin; parenteral
15.9
101.2
183
201
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
19.4
99.8
162
135
WX302
NOMESCO Finland
Thoracal epidural anesthesy
20.4
98.5
156
121
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
19.9
91.8
146
112
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
97.8
90.0
97
13
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
24.1
89.7
132
80
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
19.8
83.5
132
97
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
59.3
79.1
92
20
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
14.0
78.0
145
156
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
70.4
74.4
84
15
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
428.1
72.1
70
*
JEA00
NOMESCO Finland
Appendectomy
16.2
71.0
121
104
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
21.4
70.5
107
67
L03AA14
ATC
lipegfilgrastim; parenteral
28.5
67.6
93
42
JN4BD
NOMESCO Finland
Extensive body CT
8.8
67.3
168
303
Z51.5
ICD-10 Finland
Palliative care
13.0
65.5
124
133
L03AA13
ATC
pegfilgrastim; parenteral
14.1
58.5
105
98
JAL00
NOMESCO Finland
Biopsy of peritoneum
46.0
56.7
69
18
C574, 8461, 3
ICD-O-3
NA
+∞
56.6
53
*
LCD00
NOMESCO Finland
Hysterectomy
9.7
56.6
126
180
TPH07
NOMESCO Finland
Cathetrisation of artery
8.1
54.4
139
247
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
202.9
52.3
53
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
19.8
51.3
79
49
N02AA05
ATC
oxycodone; systemic
6.1
49.3
163
405
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
7.1
48.8
137
274
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
27.9
48.1
66
28
JAH01
NOMESCO Finland
Laparoscopy
12.3
46.9
89
91
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
11.6
45.6
89
96
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
31.9
40.2
53
19
A04AA55
ATC
palonosetron, combinations; systemic
12.5
39.3
73
70
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
22.7
39.2
57
29
ZX120
NOMESCO Finland
Intravenous
6.6
39.0
112
223
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.1
38.2
221
922
WW500
NOMESCO Finland
Blood transfusion
11.9
37.4
71
71
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
11.8
37.1
71
72
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
11.6
36.3
70
72
B01AB05
ATC
enoxaparin; parenteral
3.7
34.2
230
1061
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
24.6
34.0
48
22
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
36.9
33.9
43
13
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
45.5
33.8
41
10
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
35.9
32.9
42
13
C579, 8461, 3
ICD-O-3
NA
+∞
32.8
31
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.6
32.2
222
1027
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
17.1
31.3
50
33
TPX10
NOMESCO Finland
Implantation of vascular injection port
13.1
29.7
53
46
WX402
NOMESCO Finland
General anaesthesia
4.2
29.5
134
428
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.5
26.9
74
134
C56
ICD-10 Finland
Malignant neoplasm of ovary
31.8
26.8
35
12
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
20.4
26.2
39
21
3009
Kela drug reimbursment
Niraparib
100.1
26.0
28
*
JN4AD
NOMESCO Finland
Body CT examination
5.4
26.0
85
191
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
144.3
25.9
27
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
14.9
25.7
43
32
JAH00
NOMESCO Finland
Laparotomy
13.6
25.2
44
36
1510
Kela drug reimbursment
Niraparib
96.3
25.0
27
*
Z31.5
ICD-10 Finland
Genetic counselling
8.7
24.8
55
72
TJA10
NOMESCO Finland
Laparocentesis
60.0
24.4
28
5
1XC07
NOMESCO Finland
NA
92.5
24.0
26
*
X77
ICPC
Malignant neopl genital female other
49.9
23.6
28
6
JFB46
NOMESCO Finland
Resection of sigmoid colon
20.0
23.5
35
19
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
14.2
23.5
40
31
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
32.3
23.1
30
10
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
10.8
22.7
44
45
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
15.6
22.6
37
26
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
26.9
22.1
30
12
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
9.6
21.8
45
52
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
39.6
21.0
26
7
L01XK02
ATC
niraparib; oral
221.0
20.8
21
*
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
209.9
19.7
20
*
L02BG04
ATC
letrozole; oral
4.0
19.5
85
251
TPH04
NOMESCO Finland
Cathetrisation of vein
3.1
18.9
126
516
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.9
18.9
86
264
JMA10
NOMESCO Finland
Transabdominal total splenectomy
31.8
18.5
24
8
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
69.9
17.9
20
*
389
Kela drug reimbursment
Olaparib
+∞
16.8
16
*
1511
Kela drug reimbursment
Olaparib
+∞
16.8
16
*
8441/3-C57.0
ICD-O-3
Serous carcinoma, NOS, of fallopian tube
+∞
16.8
16
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
17.3
16.8
26
16
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.5
16.7
51
104
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.5
16.6
44
75
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
42.0
16.5
20
5
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
30.0
15.3
20
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
15.3
139
679
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
59.0
14.9
17
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
5.4
14.7
45
92
JBA10
NOMESCO Finland
Transabdominal biopsy or excision of lesion of diaphragm
83.2
14.7
16
*
L03AA02
ATC
filgrastim; parenteral
6.8
14.7
37
59
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
7.5
14.4
34
49
JFB00
NOMESCO Finland
Partial resection of small intestine
12.6
14.3
25
21
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
55.4
13.9
16
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
14.3
13.9
23
17
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.0
13.5
87
341
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
22.1
13.5
19
9
K56.7
ICD-10 Finland
Ileus, unspecified
10.2
13.4
26
27
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.1
13.2
79
295
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
7.6
13.0
30
42
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.0
12.4
40
87
JN3AD
NOMESCO Finland
Abdominal CT examination
3.6
12.2
58
182
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
8.3
12.0
26
33
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
13.1
11.8
20
16
LCA06
NOMESCO Finland
Biopsy of endometrium
2.6
11.7
95
426
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
11.6
11.7
21
19
8380/3-C57.0
ICD-O-3
Endometrioid adenocarcinoma, NOS, of fallopian tube
+∞
11.5
11
*
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
14.4
11.1
18
13
J94.8
ICD-10 Finland
Other specified pleural conditions
8.6
11.0
23
28
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
10.6
80
340
GAE03
NOMESCO Finland
Suture of chest wall
+∞
10.5
10
*
8140/3-C57.0
ICD-O-3
Adenocarcinoma, NOS, of fallopian tube
+∞
10.5
10
*
A79
ICPC
Malignancy NOS
10.0
10.4
20
21
JAL31
NOMESCO Finland
Laparoscopic omentectomy
19.4
10.3
15
8
SPAT1109
SPAT
Analgesia with portable analgesic pump
24.1
10.3
14
6
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
10.2
40
107
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
41.2
10.0
12
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
9.6
204
1388
C76.3
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Pelvis
102.4
9.5
10
*
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
30.8
9.5
12
*
L01XK01
ATC
olaparib; oral
+∞
9.4
9
*
8000/3-C57.9
ICD-O-3
Neoplasm, malignant of female genital tract, NOS
+∞
9.4
9
*
L01XX46
ATC
[U] olaparib; oral
+∞
9.4
9
*
8140/3-C57.9
ICD-O-3
Adenocarcinoma, NOS, of female genital tract, NOS
+∞
9.4
9
*
A02BC02
ATC
pantoprazole; systemic
2.1
9.4
300
2371
ZXC40
NOMESCO Finland
Use of ultrasound
11.8
9.1
16
14
A04AA02
ATC
granisetron; systemic, transdermal
3.0
9.1
52
187
D70.82
ICD-10 Finland
Drug-induced neutropenia
5.7
9.1
25
46
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
2.9
9.0
55
205
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.8
9.0
29
64
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
8.5
168
1098
JFB30
NOMESCO Finland
Right hemicolectomy
7.6
8.5
19
26
A04AA03
ATC
tropisetron; systemic
28.2
8.5
11
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
20.6
8.5
12
6
B03XA02
ATC
darbepoetin alfa; parenteral
8.1
8.5
18
23
C48.20
ICD-10 Finland
Malignant tumor in unspecified localization in the peritoneum without histology
+∞
8.4
8
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
8.4
8
*
JFF10
NOMESCO Finland
Loop enterostomy
17.6
8.1
12
7
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
34.1
8.1
10
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
34.1
8.1
10
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
6.1
8.1
21
36
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
10.3
8.1
15
15
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
4.0
8.1
31
82
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
15.4
7.8
12
8
JFA80
NOMESCO Finland
Suture of colon
45.9
7.7
9
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
18.8
7.6
11
6
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
25.6
7.6
10
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
81.5
7.4
8
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
7.1
7.4
17
25
N02BE01
ATC
paracetamol; systemic, rectal
2.5
7.3
369
3288
JJA40
NOMESCO Finland
Excision of lesion of liver
+∞
7.3
7
*
LAF17
NOMESCO Finland
Laparoscopic excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
7.3
7
*
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
16.1
7.3
11
7
R2110
NOMESCO Finland
Giving the first information
3.0
7.2
41
146
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
7.2
49
197
Z93.3
ICD-10 Finland
Colostomy status
10.3
7.1
13
13
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
7.1
60
273
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
6.9
66
317
WX704
NOMESCO Finland
Intubation
3.0
6.8
39
140
R50.9
ICD-10 Finland
Fever, unspecified
2.3
6.8
65
313
GAE06
NOMESCO Finland
Excision of lesion of chest wall
40.8
6.8
8
*
JFF30
NOMESCO Finland
Other colostomy
40.8
6.8
8
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
23.0
6.7
9
*
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
23.0
6.7
9
*
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
23.0
6.7
9
*
JFF23
NOMESCO Finland
Transversostomy
8.9
6.6
13
15
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
70.9
6.4
7
*
L01XX54
ATC
[U] niraparib; oral
70.9
6.4
7
*
KBV10
NOMESCO Finland
Removal of stent from ureter
14.6
6.4
10
7
ZX100
NOMESCO Finland
Oral
9.5
6.3
12
13
LEB00
NOMESCO Finland
Biopsy of vagina
4.9
6.3
19
40
XX1XW
NOMESCO Finland
Extensive written report from radiologist
5.2
6.3
18
36
JJB10
NOMESCO Finland
Atypcal resection of liver
27.1
6.2
8
*
R4190
NOMESCO Finland
Nutritional therapy
4.4
6.2
21
50
WX725
NOMESCO Finland
Noninvasive ventilation
3.4
6.1
28
87
Z51.88
ICD-10 Finland
Other specified medical care
5.0
6.1
18
37
D25
ICPC
Abdominal distension
5.0
6.1
18
37
M54.5
ICD-10 Finland
Low back pain
0.5
6.1
57
996
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
12.8
6.1
10
8
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
10.2
6.1
11
11
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
10.2
6.1
11
11
WVA20
NOMESCO Finland
Medicine administration
6.2
6.1
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
238
477
9.76
129.94
1.8
3.8
2.7
10.0
ug/l
3.63
149
388
102
165
7.76
63.47
2.0
2.7
26.0
998.3
u/ml
0.64
84
146
36
11
35.58
56.35
1.3
2.3
2514.8
172527.5
e6/l
—
17
6
353
1830
5.83
53.61
7.6
4.0
31.6
35.4
g/l
22.70
347
1682
345
1863
5.05
46.76
5.6
3.7
—
—
—
0
0
382
2296
6.27
43.46
31.6
8.8
3.4
4.0
e9/l
6.42
344
2008
135
445
3.94
35.65
5.7
6.4
0.7
1.5
mmol/l
1.70
120
359
32
29
11.83
30.56
1.1
1.2
—
—
—
0
0
195
977
2.80
24.05
3.0
2.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
107
5.15
22.57
2.4
2.5
0.3
0.4
u/ml
0.74
21
67
246
1422
2.67
22.35
3.9
3.2
—
—
—
0
0
33
48
7.35
21.94
1.5
1.2
1369.3
1283.1
e6/l
0.08
26
33
31
42
7.87
21.91
1.6
1.2
11879.7
212006.0
e6/l
0.65
18
22
215
1195
2.57
20.73
8.8
2.7
65.2
29.3
u/l
0.53
209
1127
293
3672
0.39
18.01
4.8
6.2
39.8
40.0
mmol/mol
0.10
259
3333
46
111
4.51
17.92
1.9
1.4
—
—
—
0
0
251
1568
2.41
17.89
7.0
3.4
2.3
2.4
mmol/l
1.91
241
1324
104
429
2.87
17.85
2.6
2.2
7.7
7.7
umol/l
0.01
91
363
365
2733
3.04
17.42
6.8
5.2
235.6
3431.9
e6/l
—
7
41
195
1123
2.33
16.35
3.5
3.1
0.7
0.5
e6/l
0.34
145
840
291
1999
2.36
15.87
8.9
4.3
0.0
0.0
estimate
0.50
67
373
289
1985
2.35
15.68
12.5
5.7
0.0
0.0
estimate
0.00
63
374
396
3168
3.66
15.59
13.6
7.2
90.5
78.3
u/l
5.79
388
2933
39
95
4.41
14.98
1.6
2.1
90.2
94.6
%
0.50
39
89
93
397
2.71
14.74
2.4
2.2
31.5
33.2
u/l
0.15
83
331
91
387
2.71
14.51
1.8
1.9
0.2
0.2
g/l
1.22
86
367
77
300
2.90
14.49
1.7
1.5
—
—
—
0
0
338
3922
0.39
13.89
4.1
5.5
2.9
2.8
mmol/l
2.32
290
3530
125
633
2.37
13.71
3.5
2.9
3.7
3.8
e6/l
0.04
62
316
322
3798
0.42
13.07
3.4
4.8
1.6
1.6
mmol/l
0.40
283
3406
286
2040
2.16
12.98
5.6
5.2
1.2
1.2
mmol/l
16.23
273
1822
130
696
2.24
12.34
3.3
2.7
1.5
1.3
e6/l
0.15
69
380
329
3827
0.43
11.86
3.5
4.8
5.0
4.8
mmol/l
2.21
286
3454
310
2331
2.14
11.59
5.9
4.4
6.7
6.6
mmol/l
0.42
302
2182
31
79
4.15
11.22
1.2
1.3
—
—
—
0
0
198
1279
2.00
11.21
4.5
2.2
55.1
56.7
u/l
0.23
189
1149
17
28
6.28
9.99
1.5
1.9
2.9
9994.6
u/l
—
10
9
290
2198
1.95
9.69
6.0
6.0
1.2
1.2
mmol/l
17.29
261
1850
264
1963
1.87
9.09
9.5
4.3
0.0
0.0
estimate
0.00
62
378
90
465
2.18
9.06
1.6
1.8
—
—
—
0
0
88
464
2.12
8.37
1.6
1.8
—
—
—
0
0
92
495
2.09
8.29
3.2
3.9
1.0
1.1
mmol/l
0.30
86
442
13
20
6.67
8.11
1.5
3.7
—
—
—
0
0
317
3654
0.52
8.07
3.1
4.2
1.3
1.3
mmol/l
1.48
278
3238
344
3849
0.50
7.45
4.4
5.0
5.9
5.9
mmol/l
0.62
308
3428
12
9
13.66
7.42
1.0
1.0
—
—
—
0
0
52
232
2.41
7.33
1.6
1.4
—
—
—
0
0
66
1191
0.47
7.31
1.4
1.6
1.4
1.3
mmol/l
0.49
58
977
126
804
1.80
6.70
1.2
1.3
—
—
—
0
0
26
85
3.19
6.58
1.4
1.3
—
—
—
0
0
26
85
3.19
6.58
1.4
1.3
—
—
—
0
0
121
781
1.76
6.12
3.2
4.2
45.9
282.8
ng/l
2.13
92
633
15
35
4.40
6.07
7.7
5.4
11.3
13.2
mg/l
1.00
15
30
22
574
0.35
5.85
3.4
4.8
29.1
34.3
%
2.47
17
348
103
642
1.79
5.84
1.7
1.8
—
—
—
0
0
76
434
1.91
5.68
3.8
3.5
—
—
—
0
0
30
118
2.66
5.50
2.1
2.3
—
—
—
0
0
414
3801
2.69
5.43
26.6
14.6
42.0
21.5
mg/l
21.62
399
3008
148
1067
1.59
4.72
9.4
4.7
0.0
0.0
estimate
0.00
62
374
127
888
1.61
4.59
3.5
2.9
2.5
2.5
mmol/l
5.04
115
772
336
3700
0.60
4.49
5.8
5.6
2.0
2.0
mu/l
0.48
303
3323
144
1891
0.64
4.41
2.0
2.3
78.8
80.9
nmol/l
0.35
127
1647
11
26
4.31
4.38
2.3
2.0
—
—
—
0
0
284
3230
0.66
4.12
4.9
4.6
15.1
15.1
pmol/l
0.07
259
2885
82
539
1.64
3.75
2.1
2.2
20.4
20.9
%
0.13
67
450
125
912
1.52
3.64
1.7
1.6
2.5
1.1
mg/l
4.15
107
712
45
751
0.55
3.54
1.1
1.3
1.1
13.8
u/ml
5.19
17
252
47
774
0.56
3.53
1.1
1.3
9.3
36.2
iu/ml
8.76
13
253
57
361
1.67
3.01
3.3
2.8
5.6
5.9
kpa
1.27
57
351
18
80
2.30
2.64
1.1
1.6
—
—
—
0
0
47
299
1.64
2.46
2.8
2.3
4.3
4.3
kpa
0.00
47
291
112
858
1.41
2.45
6.3
4.8
1.0
1.0
kg/l
0.40
12
126
149
1809
0.73
2.44
2.1
2.0
94.3
99.6
pmol/l
0.84
92
797
18
83
2.22
2.44
1.5
1.6
—
—
—
0
0
14
58
2.46
2.39
1.0
1.6
—
—
—
0
0
126
998
1.37
2.24
1.7
2.2
2.8
3.3
mg/l
1.44
111
835
104
1318
0.72
2.19
3.7
3.9
24.5
5.1
mg/mmol
1.68
60
724
9
30
3.04
2.16
1.4
1.3
43.5
17.8
ug/l
—
9
30
5
145
0.34
2.05
1.4
1.5
—
—
—
0
0
17
84
2.07
1.98
9.4
3.4
62.4
61.2
%
0.13
17
84
356
3318
1.39
1.96
38.6
16.4
35.5
38.5
%
10.23
260
2135
38
244
1.61
1.95
1.7
1.6
—
—
—
0
0
13
59
2.24
1.86
1.2
5.8
—
143.5
—
0
6
174
1481
1.29
1.83
9.6
4.6
—
—
—
0
0
17
89
1.95
1.72
1.1
1.6
—
—
—
0
0
64
846
0.71
1.71
1.7
1.7
1217.1
1223.0
nmol/l
0.02
51
598
22
127
1.77
1.67
1.2
1.2
—
—
—
0
0
23
138
1.70
1.55
1.2
1.1
—
—
—
0
0
29
187
1.59
1.50
3.6
2.1
0.6
0.6
%
0.53
29
179
15
80
1.91
1.46
10.0
3.1
5.0
4.6
e9/l
0.08
15
80
7
28
2.52
1.45
1.1
1.5
—
—
—
0
0
17
276
0.60
1.26
1.1
1.2
47.2
145.4
iu/ml
—
6
108
45
333
1.39
1.23
7.7
2.5
62.1
63.9
ml/min/173m2
0.13
25
132
22
140
1.60
1.22
1.2
1.1
—
—
—
0
0
6
127
0.47
1.18
1.2
1.4
—
—
—
0
0
284
3027
0.82
1.13
2.9
4.5
20.5
13.9
mm/h
6.08
259
2742
7
30
2.35
1.13
1.1
1.4
—
—
—
0
0
10
51
1.98
1.12
1.0
1.4
—
—
—
0
0
414
4035
1.49
1.08
45.9
17.5
70.3
71.2
umol/l
0.35
414
4035
9
47
1.93
1.02
1.0
1.5
3.3
84.9
u/ml
—
9
47
9
47
1.93
1.02
1.0
1.5
—
—
—
0
0
21
140
1.53
0.99
1.1
1.3
—
—
—
0
0
0
30
0.00
0.97
0.0
1.4
—
—
—
0
0
6
116
0.51
0.95
1.3
1.4
—
—
—
0
0
7
128
0.54
0.89
1.6
1.5
1.0
1.2
g/l
—
7
122
26
186
1.42
0.89
2.2
2.7
24.8
25.4
mmol/l
0.49
26
181
32
240
1.36
0.85
3.7
2.5
115.9
125.8
g/l
1.60
32
234
8
139
0.57
0.84
1.6
1.6
—
—
—
0
0
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
0
25
0.00
0.79
0.0
1.0
—
1.2
—
0
14
8
48
1.68
0.79
1.0
1.5
—
—
—
0
0
7
123
0.56
0.79
1.3
1.6
0.2
0.2
g/l
—
7
117
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
11
67
1.66
0.75
1.2
1.6
—
—
—
0
0
8
136
0.58
0.74
1.1
1.5
—
—
—
0
0
9
57
1.59
0.71
1.2
1.7
—
—
—
0
0
9
143
0.62
0.71
1.2
1.2
—
15.9
—
0
10
14
93
1.52
0.70
1.4
1.2
—
—
—
0
0
249
2347
1.14
0.68
5.7
2.9
69.4
46.2
u/l
1.73
230
2119
5
29
1.73
0.64
3.8
2.0
—
—
—
0
0
64
551
1.19
0.59
10.5
7.1
—
—
—
0
0
0
23
0.00
0.58
0.0
1.4
—
15.7
—
0
16
5
90
0.55
0.56
2.0
3.3
26.2
26.0
mmol/l
—
5
78
9
132
0.68
0.52
4.7
3.6
24.5
25.1
mmol/l
—
9
125
10
145
0.68
0.51
1.9
1.7
—
—
—
0
0
167
1566
1.11
0.46
3.0
3.7
28.3
51.4
ng/l
0.50
126
1140
15
112
1.35
0.45
2.1
1.6
4.4
4.9
iu/l
—
7
33
375
3671
1.15
0.45
37.4
14.0
76.2
75.1
ml/min/173m2
0.48
337
2999
24
193
1.26
0.44
1.2
1.3
—
—
—
0
0
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
5
32
1.57
0.42
1.4
1.5
—
—
—
0
0
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
106
976
1.11
0.41
2.6
2.4
7245.1
6898.3
umol/l
0.02
100
805
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
0
17
0.00
0.40
0.0
5.9
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
7
105
0.66
0.39
1.1
1.2
—
8.9
—
0
11
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
18
143
1.27
0.37
1.4
1.3
264.7
291.4
ug/g
0.33
12
84
9
69
1.31
0.37
1.1
1.1
—
—
—
0
0
10
134
0.74
0.35
1.2
1.6
—
106.7
—
0
6
10
134
0.74
0.35
1.6
1.7
—
—
—
0
0
6
44
1.37
0.34
1.2
1.2
—
—
—
0
0
419
4149
1.24
0.34
55.1
22.1
4.0
4.4
e12/l
43.43
411
4023
6
45
1.34
0.34
1.0
1.0
—
—
—
0
0
6
46
1.31
0.33
1.8
1.5
—
—
—
0
0
6
47
1.28
0.32
1.2
1.7
—
—
—
0
0
50
550
0.90
0.27
1.5
1.3
—
—
—
0
0
5
75
0.66
0.26
1.0
1.7
—
—
—
0
0
15
179
0.83
0.23
1.7
2.3
—
—
—
0
0
11
136
0.80
0.23
2.0
2.3
0.0
0.0
g/l
0.00
11
126
86
913
0.93
0.23
1.1
1.2
0.5
1.6
u/ml
1.87
21
227
5
39
1.29
0.23
1.6
2.1
—
—
—
0
0
99
1045
0.93
0.22
1.8
1.5
18.8
22.6
nmol/l
3.12
93
858
7
93
0.75
0.22
1.0
1.1
3.6
3.8
mmol/l
—
7
86
11
135
0.81
0.22
2.0
2.3
0.0
0.0
g/l
0.00
11
125
17
199
0.85
0.22
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
4.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
188
1937
0.95
0.20
2.4
2.4
—
—
—
0
0
6
53
1.13
0.18
1.5
1.3
—
—
—
0
0
6
79
0.76
0.15
1.2
1.2
—
—
—
0
0
18
161
1.12
0.13
1.1
1.2
—
—
—
0
0
13
148
0.87
0.12
1.8
2.3
37.3
37.8
g/l
0.12
13
133
5
45
1.11
0.10
2.8
3.7
—
—
—
0
0
6
54
1.11
0.09
1.5
1.3
—
—
—
0
0
6
54
1.11
0.09
1.5
1.3
—
—
—
0
0
6
54
1.11
0.09
1.5
1.3
—
—
—
0
0
6
54
1.11
0.09
1.5
1.3
—
—
—
0
0
9
104
0.86
0.06
1.0
1.2
540.7
523.6
mg/l
—
9
97
10
109
0.92
0.04
1.6
1.7
—
—
—
0
0
131
1296
1.02
0.03
2.3
2.9
1229.7
1090.6
ng/l
0.24
120
1090
13
123
1.06
0.01
1.2
1.4
—
—
—
0
0
13
137
0.95
0.01
1.8
2.4
0.0
0.0
g/l
0.50
13
127
14
134
1.05
0.00
1.8
1.9
72.4
186.4
ug/l
3.22
14
120
91
909
1.00
0.00
1.6
1.7
97436479.7
17440684.9
pmol/l
0.38
78
711
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
5
54
0.93
0.00
1.6
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
16.2
—
78.2
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
107.5
—
0
6
0
6
0.00
0.00
0.0
1.2
—
7.6
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
60
1.00
0.00
1.3
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
65
0.92
0.00
1.5
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
88.3
—
0
7
0
8
0.00
0.00
0.0
7.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_FEMALE_GENITAL_NAS – Malignant neoplasm of other and unspecified female genital organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).